Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbal Medicine in Primary Dysmenorrhea
NCT06187376Phase 2Withdrawn
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2024
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Elix Cycle Balance in primary dysmenorrhea (PD) (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Presence or absence of any adverse events at 3 months. Planned start Jul 2024; status: withdrawn.
02
Drugs
Elix Cycle Balance
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06187376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06187376.